Citigroup

Filing Details

13F-HR • 2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-12
Total Holdings
8,340
Total Value
44847690535
Accession Number
0000831001-25-000103
Form Type
13F-HR
Manager Name
Citigroup
Data Enrichment
86% identified
7,168 identified1,172 unidentified

Holdings

8,340 positions • $44.8B total value
Manager:
Search and click to pin securities to the top
Page 220 of 239
Lyell Immunopharma, Inc.
Shares:2.6K
Value:$1.4K
% of Portfolio:0.0% ($1.4K/$44.8B)
TSS, Inc.
Shares:176
Value:$1.4K
% of Portfolio:0.0% ($1.4K/$44.8B)
MediWound Ltd.
Shares:89
Value:$1.4K
% of Portfolio:0.0% ($1.4K/$44.8B)
MARINE PRODUCTS CORP
Shares:164
Value:$1.4K
% of Portfolio:0.0% ($1.4K/$44.8B)
Kodiak Sciences Inc.
Shares:490
Value:$1.4K
% of Portfolio:0.0% ($1.4K/$44.8B)
Citi Trends Inc
Shares:62
Value:$1.4K
% of Portfolio:0.0% ($1.4K/$44.8B)
ONE Group Hospitality, Inc.
Shares:454
Value:$1.4K
% of Portfolio:0.0% ($1.4K/$44.8B)
Brand Engagement Network Inc.
Shares:66.7K
Value:$1.4K
% of Portfolio:0.0% ($1.4K/$44.8B)
08659B102
Shares:110
Value:$1.3K
% of Portfolio:0.0% ($1.3K/$44.8B)
68248T204
Shares:200
Value:$1.3K
% of Portfolio:0.0% ($1.3K/$44.8B)
ROCKY BRANDS, INC.
Shares:77
Value:$1.3K
% of Portfolio:0.0% ($1.3K/$44.8B)
SMITH MIDLAND CORP
Shares:43
Value:$1.3K
% of Portfolio:0.0% ($1.3K/$44.8B)
Neurogene Inc.
Shares:114
Value:$1.3K
% of Portfolio:0.0% ($1.3K/$44.8B)
InflaRx N.V.
Shares:1.3K
Value:$1.3K
% of Portfolio:0.0% ($1.3K/$44.8B)
PUMA BIOTECHNOLOGY, INC.
Shares:447
Value:$1.3K
% of Portfolio:0.0% ($1.3K/$44.8B)
Cartesian Therapeutics, Inc.
Shares:99
Value:$1.3K
% of Portfolio:0.0% ($1.3K/$44.8B)
PepGen Inc.
Shares:918
Value:$1.3K
% of Portfolio:0.0% ($1.3K/$44.8B)
CS Disco, Inc.
Shares:311
Value:$1.3K
% of Portfolio:0.0% ($1.3K/$44.8B)
NEKTAR THERAPEUTICS
Shares:1.9K
Value:$1.3K
% of Portfolio:0.0% ($1.3K/$44.8B)
ACACIA RESEARCH CORP
Shares:395
Value:$1.3K
% of Portfolio:0.0% ($1.3K/$44.8B)